{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:46:05Z","timestamp":1792021565294,"version":"4.4.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472636"],"award-info":[{"award-number":["82472636"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.critrevonc.2026.105647","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:59:15Z","timestamp":1791820755000},"page":"105647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor-associated immunosenescence: Mechanisms, biomarkers and age-adaptive immunotherapy"],"prefix":"10.1016","volume":"228","author":[{"given":"Hongjiao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guogui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.critrevonc.2026.105647_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.exger.2006.11.007","article-title":"Dendritic cells in human aging","volume":"42","author":"Agrawal","year":"2007","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri2959","article-title":"Are senescence and exhaustion intertwined or unrelated processes that compromise immunity","volume":"11","author":"Akbar","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41419-025-07636-7","article-title":"Addition of metformin to anti-PD-1\/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients","volume":"16","author":"Amato","year":"2025","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105647_bib4","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.166.3.1524","article-title":"Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice","volume":"166","author":"Andrew","year":"2001","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105647_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052120","article-title":"Immunotherapy for elderly patients with advanced non-small cell lung cancer: challenges and perspectives","volume":"26","author":"Baladi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105647_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1413067","article-title":"Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy","volume":"15","author":"Bao","year":"2024","journal-title":"Front. Immunol."},{"issue":"7077","key":"10.1016\/j.critrevonc.2026.105647_bib7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2005","journal-title":"Nature"},{"issue":"7600","key":"10.1016\/j.critrevonc.2026.105647_bib8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature17655","article-title":"Normalizing the environment recapitulates adult human immune traits in laboratory mice","volume":"532","author":"Beura","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105647_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107318","article-title":"Pembrolizumab as first-line treatment for advanced NSCLC in older adults: a phase II clinical trial evaluating geriatric and quality-of-life outcomes","volume":"183","author":"Blanco","year":"2023","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105647_bib10","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1182\/blood-2002-07-2103","article-title":"Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells","volume":"101","author":"Brenchley","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105647_bib11","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.4049\/jimmunol.1302064","article-title":"Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling","volume":"192","author":"Britanova","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105647_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-immunol-092419-031130","article-title":"Age-associated B cells","volume":"38","author":"Cancro","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105647_bib13","article-title":"ALT-803 in the treatment of non-muscle-invasive bladder cancer: preclinical and clinical evidence and translational potential","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105647_bib14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s11912-024-01528-3","article-title":"Immune checkpoint inhibitors in geriatric oncology","volume":"26","author":"Cook","year":"2024","journal-title":"Curr. Oncol. Rep."},{"issue":"6963","key":"10.1016\/j.critrevonc.2026.105647_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature02118","article-title":"A DNA damage checkpoint response in telomere-initiated senescence","volume":"426","author":"d'Adda di Fagagna","year":"2003","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105647_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2326-6066.CIR-13-0171","article-title":"Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade","volume":"2","author":"Da Silva","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"26","key":"10.1016\/j.critrevonc.2026.105647_bib17","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.23.00933","article-title":"Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update","volume":"41","author":"Dale","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105647_bib18","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/2326-6066.CIR-19-0360","article-title":"Anti-VEGF treatment enhances cd8(+) t-cell antitumor activity by amplifying hypoxia","volume":"8","author":"De Almeida","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105647_bib19","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105647_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41571-024-00959-y","article-title":"Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks","volume":"22","author":"Diorio","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105647_bib21","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41568-025-00858-z","article-title":"Ageing, immune fitness and cancer","volume":"25","author":"Dolan","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib22","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1186\/s12967-025-07272-x","article-title":"Lactate at the crossroads of tumor metabolism and immune escape: a new frontier in cancer therapy","volume":"23","author":"Dong","year":"2025","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib23","first-page":"1878","article-title":"Beyond pills and prescriptions: Exploring aging-related diseases with non-pharmacological strategies and molecular innovations","volume":"16","author":"Esmaeilzadeh","year":"2025","journal-title":"Aging Dis."},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105647_bib24","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/jnci\/djq364","article-title":"Therapy-induced senescence in cancer","volume":"102","author":"Ewald","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105647_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12979-025-00550-8","article-title":"CD8\u207a T cell heterogeneity in aging: insights from single-cell profiling","volume":"23","author":"Filippov","year":"2025","journal-title":"Immun. Ageing"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105647_bib27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41577-018-0052-0","article-title":"Immune-boost for the elderly","volume":"18","author":"Flemming","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105647_bib28","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.20100637","article-title":"Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients","volume":"207","author":"Fourcade","year":"2010","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105647_bib29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105647_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-0716-1507-2_6","article-title":"Methods for characterization of senescent circulating and tumor-infiltrating T-Cells: an overview from multicolor flow cytometry to single-cell RNA sequencing","volume":"2325","author":"Franzin","year":"2021","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41392-025-02371-z","article-title":"Immunosenescence: signaling pathways, diseases and therapeutic targets","volume":"10","author":"Fu","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105647_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12016-021-08899-6","article-title":"Immunology of aging: the birth of inflammaging","volume":"64","author":"Fulop","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","article-title":"Cellular senescence: defining a path forward","volume":"179","author":"Gorgoulis","year":"2019","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105647_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12121314","article-title":"Immunosenescence: aging and immune system decline","volume":"12","author":"Goyani","year":"2024","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105647_bib35","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1182\/blood-2006-02-004531","article-title":"Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells","volume":"108","author":"Gray","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105647_bib36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.celrep.2015.07.008","article-title":"Metabolic damage and premature thymus aging caused by stromal catalase deficiency","volume":"12","author":"Griffith","year":"2015","journal-title":"Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105647_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1563303","article-title":"Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives","volume":"16","author":"Gu","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105647_bib38","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.21037\/tlcr-20-941","article-title":"Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis","volume":"10","author":"Guaitoli","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"issue":"1\u20134","key":"10.1016\/j.critrevonc.2026.105647_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/aac2.12014","article-title":"Aging and immunotherapies: New horizons for the golden ages","volume":"1","author":"Hamilton","year":"2020","journal-title":"Aging Cancer"},{"issue":"6274","key":"10.1016\/j.critrevonc.2026.105647_bib40","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/345458a0","article-title":"Telomeres shorten during ageing of human fibroblasts","volume":"345","author":"Harley","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105647_bib41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","article-title":"The serial cultivation of human diploid cell strains","volume":"25","author":"Hayflick","year":"1961","journal-title":"Exp. Cell. Res."},{"issue":"Pt B","key":"10.1016\/j.critrevonc.2026.105647_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.arr.2015.10.003","article-title":"Immunesenescence and inflammaging: A contributory factor in the poor outcome of the geriatric trauma patient","volume":"24","author":"Hazeldine","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105647_bib43","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/s43018-025-00982-7","article-title":"Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure","volume":"6","author":"Hope","year":"2025","journal-title":"Nat. Cancer"},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105647_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910389","article-title":"A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT\/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers","volume":"22","author":"Hosseinkhani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105647_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112810","article-title":"The Evolving Role of CD8(+)CD28(-) Immunosenescent T Cells in Cancer Immunology","volume":"20","author":"Huff","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105647_bib46","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI133353","article-title":"Minimal PD-1 expression in mouse and human NK cells under diverse conditions","volume":"130","author":"Judge","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105647_bib47","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jgo.2019.05.013","article-title":"Efficacy of immune checkpoint inhibitors in older adults with advanced stage cancers: A meta-analysis","volume":"11","author":"Kasherman","year":"2020","journal-title":"J. Geriatr. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105647_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100577","article-title":"The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression","volume":"7","author":"Kim","year":"2022","journal-title":"ESMO Open."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105647_bib49","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1007\/s10238-023-01035-y","article-title":"Systemic immune-inflammation index predicts prognosis and responsiveness to immunotherapy in cancer patients: a systematic review and meta\u2011analysis","volume":"23","author":"Kou","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105647_bib50","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1101\/gr.192237.115","article-title":"Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells","volume":"25","author":"Kowalczyk","year":"2015","journal-title":"Genome Res."},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105647_bib51","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1158\/1078-0432.CCR-18-1116","article-title":"Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations","volume":"24","author":"Kugel","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000842","article-title":"Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition","volume":"8","author":"Laino","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1474-9726.2010.00584.x","article-title":"Human NK cells display major phenotypic and functional changes over the life span","volume":"9","author":"Le Garff-Tavernier","year":"2010","journal-title":"Aging Cell."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib54","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.18632\/aging.205581","article-title":"Exploring the effects of Dasatinib, Quercetin, and Fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions","volume":"16","author":"Lee","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.critrevonc.2026.105647_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1117092","article-title":"IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation","volume":"14","author":"Lee","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib56","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s43587-025-00819-z","article-title":"Single-cell immune aging clocks reveal inter-individual heterogeneity during infection and vaccination","volume":"5","author":"Li","year":"2025","journal-title":"Nat. Aging"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","article-title":"Immunosenescence: a key player in cancer development","volume":"13","author":"Lian","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105647_bib58","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","article-title":"Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition","volume":"184","author":"Litchfield","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1474-9726.2009.00489.x","article-title":"Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging","volume":"8","author":"Liu","year":"2009","journal-title":"Aging Cell."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105647_bib61","article-title":"Targeting immunosenescence for improved tumor immunotherapy","volume":"5","author":"Liu","year":"2024","journal-title":"MedComm (2020)"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105647_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103657","article-title":"Adequate assessment yields appropriate care\u2014the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO\/SIOG Cancer in the Elderly Working Group","volume":"9","author":"Loh","year":"2024","journal-title":"ESMO Open."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105647_bib63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mito.2013.01.003","article-title":"Mitochondrial dysfunction and the inflammatory response","volume":"13","author":"L\u00f3pez-Armada","year":"2013","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib64","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1186\/s12885-020-07284-4","article-title":"Identifying predictive biomarkers of CIMAvaxEGF success in non-small cell lung cancer patients","volume":"20","author":"Lorenzo-Luaces","year":"2020","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105647_bib65","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.it.2009.04.003","article-title":"Thymic involution and immune reconstitution","volume":"30","author":"Lynch","year":"2009","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105647_bib66","doi-asserted-by":"crossref","first-page":"e009258","DOI":"10.1136\/jitc-2024-009258","article-title":"Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018\u20132022","volume":"12","author":"Mac Eochagain","year":"2024","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib67","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/s41467-024-46769-9","article-title":"Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment","volume":"15","author":"Maggiorani","year":"2024","journal-title":"Nat. Commun."},{"issue":"268","key":"10.1016\/j.critrevonc.2026.105647_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105647_bib69","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer","volume":"37","author":"Mclane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib70","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.4049\/jimmunol.1700148","article-title":"Human Monocyte Subsets Are Transcriptionally and Functionally Altered in Aging in Response to Pattern Recognition Receptor Agonists","volume":"199","author":"Metcalf","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105647_bib71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.csbj.2024.08.018","article-title":"Methylation and transcriptomic profiling reveals short term and long term regulatory responses in polarized macrophages","volume":"25","author":"Migliaccio","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105647_bib72","doi-asserted-by":"crossref","first-page":"724","DOI":"10.18632\/aging.101774","article-title":"CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age","volume":"11","author":"M\u00fcller-Durovic","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"45","key":"10.1016\/j.critrevonc.2026.105647_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh0708","article-title":"Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8(+) T cells in patients with advanced NSCLC","volume":"9","author":"Naigeon","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.critrevonc.2026.105647_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4807853","article-title":"Interleukin-7 and Immunosenescence","volume":"2017","author":"Nguyen","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib75","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12979-021-00230-3","article-title":"High-dimensional single cell mass cytometry analysis of the murine hematopoietic system reveals signatures induced by ageing and physiological pathogen challenges","volume":"18","author":"Nikolaou","year":"2021","journal-title":"Immun. Ageing"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","article-title":"The twilight of immunity: emerging concepts in aging of the immune system","volume":"19","author":"Nikolich-\u017dugich","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105647_bib77","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ctrv.2016.02.006","article-title":"Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis","volume":"45","author":"Nishijima","year":"2016","journal-title":"Cancer Treat. Rev."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105647_bib78","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","article-title":"Immunometabolism and natural killer cell responses","volume":"19","author":"O'Brien","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105647_bib79","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7148","key":"10.1016\/j.critrevonc.2026.105647_bib80","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nature05894","article-title":"Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance","volume":"447","author":"Odegaard","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105647_bib81","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fimmu.2013.00316","article-title":"The effect of age on thymic function","volume":"4","author":"Palmer","year":"2013","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105647_bib82","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virusres.2010.09.010","article-title":"Role of CMV in immune senescence","volume":"157","author":"Pawelec","year":"2011","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib83","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1038\/s41467-019-10335-5","article-title":"Senescent cells evade immune clearance via HLA-E-mediated NK and CD8(+) T cell inhibition","volume":"10","author":"Pereira","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105647_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.713132","article-title":"Polyfunctional KLRG-1(+)CD57(+) Senescent CD4(+) T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients","volume":"12","author":"Ramello","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib85","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105647_bib86","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105647_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/biom15060860","article-title":"Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions","volume":"15","author":"Saliev","year":"2025","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105647_bib88","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00109-019-01795-9","article-title":"AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging","volume":"97","author":"Salminen","year":"2019","journal-title":"J. Mol. Med. (Berl. )"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105647_bib89","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1158\/0008-5472.CAN-24-4317","article-title":"Age-Associated Modulation of TREM1\/2-Expressing Macrophages Promotes Melanoma Progression and Metastasis","volume":"85","author":"Scortegagna","year":"2025","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105647_bib90","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","article-title":"Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a","volume":"88","author":"Serrano","year":"1997","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105647_bib91","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105647_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106921","article-title":"An immune risk score with potential implications in prognosis and immunotherapy of metastatic melanoma","volume":"88","author":"Sheng","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105647_bib93","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1078-0432.CCR-09-1303","article-title":"Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy","volume":"16","author":"Sport\u00e8s","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib94","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12979-023-00374-4","article-title":"Towards a better preclinical cancer model - human immune aging in humanized mice","volume":"20","author":"Tan","year":"2023","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.critrevonc.2026.105647_bib95","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12979-020-0173-8","article-title":"Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging","volume":"17","author":"Thomas","year":"2020","journal-title":"Immun. Ageing"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105647_bib96","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/annonc\/mdz108","article-title":"Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers","volume":"30","author":"Trebeschi","year":"2019","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib97","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13046-024-02969-1","article-title":"Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade","volume":"43","author":"Tsai","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib98","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaoncol.2023.6277","article-title":"Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer","volume":"10","author":"Tsukita","year":"2024","journal-title":"JAMA Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105647_bib99","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"6013","key":"10.1016\/j.critrevonc.2026.105647_bib100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib101","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12964-025-02082-6","article-title":"Immunosenescence promotes cancer development: from mechanisms to treatment strategies","volume":"23","author":"Wang","year":"2025","journal-title":"Cell. Commun. Signal."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib102","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13287-025-04360-z","article-title":"Clinical application of mesenchymal stem cells in immunosenescence: a qualitative review of their potential and challenges","volume":"16","author":"Wang","year":"2025","journal-title":"Stem Cell. Res. Ther."},{"key":"10.1016\/j.critrevonc.2026.105647_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1418508","article-title":"Integrated machine learning identifies a cellular senescence-related prognostic model to improve outcomes in uterine corpus endometrial carcinoma","volume":"15","author":"Wei","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105647_bib104","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","article-title":"CD28(-) T cells: their role in the age-associated decline of immune function","volume":"30","author":"Weng","year":"2009","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105647_bib105","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.immuni.2007.11.006","article-title":"Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105647_bib106","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/gerona\/60.5.556","article-title":"An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans","volume":"60","author":"Wikby","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"2-3","key":"10.1016\/j.critrevonc.2026.105647_bib107","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0047-6374(97)00151-6","article-title":"Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study","volume":"102","author":"Wikby","year":"1998","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.critrevonc.2026.105647_bib108","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djag157","article-title":"Pembrolizumab with or without chemotherapy among older adults with advanced lung adenocarcinoma: a national, nonrandomized open-label phase II trial (Alliance A171901)","author":"Wong","year":"2026","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib109","article-title":"Correlation between patients' age and cancer immunotherapy efficacy","volume":"8","author":"Wu","year":"2019","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105647_bib110","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s43587-024-00597-0","article-title":"Targeting aging and age-related diseases with vaccines","volume":"4","author":"Wu","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.critrevonc.2026.105647_bib111","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8426874","article-title":"An update on inflamm-aging: mechanisms, prevention, and treatment","volume":"2016","author":"Xia","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105647_bib112","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jb\/mvae079","article-title":"Cellular senescence: mechanisms and relevance to cancer and aging","volume":"177","author":"Yamauchi","year":"2025","journal-title":"J. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105647_bib113","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41467-024-46020-5","article-title":"The long and winding road of reprogramming-induced rejuvenation","volume":"15","author":"Y\u00fccel","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105647_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103409","article-title":"Senescent T cells: a potential biomarker and target for cancer therapy","volume":"68","author":"Zhang","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.critrevonc.2026.105647_bib115","article-title":"Age-related differences in molecular profiles for immune checkpoint blockade therapy","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105647_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06721-7","article-title":"The cell cycle regulator p16 promotes tumor infiltrated CD8+ T cell exhaustion and apoptosis","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105647_bib117","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-023-01426-4","article-title":"Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications","volume":"16","author":"Zhao","year":"2023","journal-title":"J. Hematol. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:53:25Z","timestamp":1792018405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826005342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":117,"alternative-id":["S1040842826005342"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105647","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-associated immunosenescence: Mechanisms, biomarkers and age-adaptive immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105647"}}